The novel etomidate analog: A potential induction agent
Saudi Journal of Anaesthesia · 2025-10 · 19 (4) · 614-616
DOI: 10.4103/sja.sja_503_25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Saudi Journal of Anaesthesia, online erschienen am 03.09.2025. Verfasst von Konica Chittoria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care, AIIMS, Jodhpur, Rajasthan, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Etomidate is the agent of choice for the induction of anesthesia in patients with cardiovascular illness, hypotension, or shock. Notwithstanding its numerous attributes, etomidate’s most notable adverse impact is adrenocortical suppression. Due to these concerns, the creation of an etomidate alternative that maintains its beneficial effects while mitigating adverse outcomes became essential. This article will focus on the new etomidate analog, methoxyethyl etomidate hydrochloride, referred to as ET-26.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care, AIIMS, Jodhpur, Rajasthan, India.
- Department of Trauma and Emergency (Anesthesiology and Critical Care), AIIMS, Jodhpur, Rajasthan, India.
Zitieren
APA
Chittoria, K., & Sharma, A. (2025). The novel etomidate analog: A potential induction agent. Saudi Journal of Anaesthesia, 19(4), 614-616. https://doi.org/10.4103/sja.sja_503_25
Vancouver
Chittoria K, Sharma A. The novel etomidate analog: A potential induction agent. Saudi Journal of Anaesthesia. 2025;19(4):614-616. doi:10.4103/sja.sja_503_25
BibTeX
@article{Chittoria2025,
author = {Chittoria, Konica and Sharma, Ankur},
title = {The novel etomidate analog: A potential induction agent},
journal = {Saudi Journal of Anaesthesia},
year = {2025},
volume = {19},
number = {4},
pages = {614--616},
doi = {10.4103/sja.sja_503_25}
}
EUVIMED